Lupin Limited

Form 483 issued May 19, 2017 · Indore, India

Inspection
May 8 – May 19, 2017
Observations
1
Pages
7
FEI number
3007549629

In short: On May 19, 2017, FDA issued a Form 483 with 1 observation to Lupin Limited in Indore, India (FEI 3007549629) after an inspection that ran May 8 – May 19, 2017. The investigators were Darren S. Brown and Tamil Arasu. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lupin Limited?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Lupin Limited?

Darren S. Brown and Tamil Arasu are named on this Form 483, for the inspection of May 8 – May 19, 2017. Each investigator has a profile showing what they cite most.

When was Lupin Limited inspected by FDA?

The inspection ran May 8 – May 19, 2017, and the Form 483 is dated May 19, 2017.

How do I get the full Form 483 for Lupin Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free